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Obesity has been associated with high bone mineral density (BMD) but a greater propensity to fracture. Some obese individuals have
increased marrow adipose tissue (MAT), but the impact of MAT on bone turnover remains controversial, as do changes in BMD associated
with a high fat diet (HFD). In this study we hypothesized that MAT volumewould increase in response toHFD but would be independent of
changes in BMD. Hence, we fed C57BL/6J (B6) male mice at 3 weeks of age either a high fat diet (60 kcal %) or regular diet (10 kcal %) for
12 weeks (n¼ 10/group). We measured MAT volume by osmium staining and micro-CT (mCT) as well as bone parameters by mCT,
histomorphometry, and dual-energy X-ray absorptiometry. We also performed a short-term pilot study using 13-week-old B6 males and
females fed a HFD (58 kcal %) for 2 weeks (n¼ 3/sex). Both long- and short-term HFD feedings were associated with high MAT volume,
however, femoral trabecular bone volume fraction (BV/TV), bone formation rate and cortical bonemass were not altered in the long-term
study. In the short-term pilot study, areal BMD was unchanged after 2 weeks of HFD.We conclude that, for B6 mice fed a HFD starting at
wean or 13 weeks of age, MAT increases whereas bone mass is not altered. More studies are needed to define the mechanism responsible
for the rapid storage of energy in the marrow and its distinction from other adipose depots.
J. Cell. Physiol. 230: 2032–2037, 2015.  2015 Wiley Periodicals, Inc.
Obesity is a chronic condition associated with significant
morbidity and a long-term risk of cardiovascular disease and
cancer. The effects of visceral obesity are pronounced on
target tissues such as the vasculature and are likely related to
the inflammatory nature of the adipose depot and the
cytokines released from those cells. Notwithstanding, the
relationship of obesity to osteoporosis is controversial. Obese
individuals tend to have higher areal bone mineral density
(aBMD) based on body size (Rosen and Klibanski, 2009; Zaidi
et al., 2012). However, a recent cohort study of older men
(MrOs) as well as a registry study of postmenopausal women
from England suggested that obesity was a major risk factor for
fractures (Premaor et al., 2010; Nielson et al., 2012). In
addition, several studies in children have shown that obesity
increases the risk for radial fractures (Ryan, 2010). With
respect to skeletal microarchitecture, Bredella et al. (2011)
demonstrated that visceral adiposity was negatively associated
with lumbar volumetric BMDmeasured by QCT, but positively
related to marrow adipose volume by MRI. In contrast, it was
shown that obese young and old individuals have higher
trabecular bone volume fractions in the radius and tibia than
healthy controls (Dimitri et al., 2014, Evans et al., 2014).
Therefore, the role of obesity in regulating bone turnover and
skeletal fragility remains unclear.
A similar paradox has been noted inmice; C57BL/6J (B6), the
most commonly used inbred strain, has a genetic
predisposition to obesity and diabetes, particularly when fed a
high fat diet (HFD). This weight gain, seen in both young and
aging mice, is associated with visceral adiposity, insulin
resistance and, in some instances, bone loss (Cao et al., 2010;
Patsch et al., 2011). Previous studies have demonstrated that
marrow adipose tissue (MAT) is increased in B6 mice fed a
HFD (Lecka-Czernik et al., 2015). Strain, age, gender,
composition of the diet, duration of feeding, and the
microbiome of the laboratory mouse likely play important
roles in determining the effects of a HFD on bone marrow
composition and ultimately the skeletal response.
Recent work from our laboratory and elsewhere has shown
that somemurine strains lose bone with a HFD and have higher
MAT, while others do not (Rosen et al., 2004; Beamer et al.,
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2011). These findings are reminiscent of earlier studies with
inbred strains treated with rosiglitazone (Ackert-Bicknell et al.,
2009). For example, Le et al. (2012) showed that 13 weeks of
HFD feeding beginning at weaning caused bone loss in mice
with a deletion of Alox5, a lipoxygenase important in the
synthesis of inflammatory mediators, but not in B6 littermates.
In the 6T congenic mouse strain, which is 99.6% genetically
identical to B6 but carrying a small segment of the C3H/HeJ
(C3H) genome, a modified HFD resulted in greatly enhanced
MAT volume and profound bone loss due to increased bone
resorption (Bonnet et al., 2014). On the other hand, in the
same experiment, B6 littermates showed little change in bone
mass and only slight increases in MAT. To better understand
the interrelationship of diet, MAT, and BMD, we studied the
effects of an obesogenic diet on bone mass and MAT in B6mice
following long- (84 days, starting at 3 weeks of age in males)
or short-term (14 days, starting at 13 weeks of age in males
and females) feeding. We found that consumption of a HFD
rapidly increases the volume of MAT, but has little or no
effect on trabecular and cortical compartments as measured
by dual-energy X-ray absorptiometry, histomorphometry, and
micro-computed tomography.
Materials and Methods
Animals
C57BL/6J were derived from a stock strain (stock# 000664, The
Jackson Laboratory, Bar Harbor, ME) and were maintained at
the Maine Medical Center Research Institute animal facility on a
12/12 h light/dark cycle with ad libitum access to food and water.
Mice were euthanized by CO2 inhalation and decapitation. All
animal studies were reviewed and approved by the Institutional
Animal Care and Use Committee at the Maine Medical Center
Research Institute.
Diet manipulation
Long-term study. At 3 weeks of age, C57BL/6J male mice
(n¼ 10 per group) were randomly assigned to either control
(10% kcal from fat, cat# D12450B, Research Diets, Inc., New
Brunswick, NJ) or high fat diet (HFD, 60% kcal from fat, cat#
D12492, Research Diets, Inc.). Mice were group-housed and fed
ad libitum for a period of 12 weeks, at which time they were
sacrificed and tissues were collected for analysis.
Short-term pilot study. Thirteen-week-old male (n¼ 3)
and female (n¼ 3) C57BL/6J mice weremaintained on a Surwit diet
(58% kcal from fat, cat# D12331, Research Diets, Inc.) for 14 days,
at which time they were sacrificed and tissues were collected for
analysis.
Serum analysis
Serum concentrations of dickkopf-related protein-1 (DKK1),
fibroblast growth factor 23 (FGF23), interleukin 6 (IL-6), insulin,
leptin, osteoprotegerin (OPG), osteocalcin (OC), sclerostin
(SOST), and tumor necrosis factor alpha (TNFa) were measured
using the Milliplex mouse bone metabolism multiplex assay (cat#
MBNMAG-41K, EMD Millipore, Billerica, MA) and a Luminex 200
xMAP platform for detection (cat# 40-012, EMD Millipore).
Body composition
Dual-energy X-ray absorptiometry (DXA). Areal bone
mineral density (BMD) and body composition measurements
(excluding the head) were taken using a PIXImus Densitometer
(GE-Lunar Corp., Madison, WI). The instrument was calibrated
daily using a phantom standard provided by the manufacturer.
Nuclear magnetic resonance spectroscopy (NMR).
Body composition (body fat, lean mass, and free fluid) was analyzed
by Minispec NMR (Bruker). A quality control check of NMR
parameters using a standard provided by the manufacturer was
performed prior to testing.
Bone length
Bone length wasmeasured using Traceable1 digital calipers (mod#
62379-531, Control Company, Friendswood, TX). Measurements
were taken from the greater trochanter to the lateral and medial
condyles.
Micro-computed tomography (mCT)
Microarchitecture of femoral trabecular and cortical bone was
assessed post-mortem by high-resolution micro-computed
tomography (MicroCT40, Scanco Medical AG, Br€uttisellen,
Switzerland). Approximately 100 CT slices with an isotropic voxel
size of 12mmwere taken just proximal to the distal growth plate of
the femur for trabecular bone measurements. For cortical bone
measurements, 18 CT slices were obtained from the mid-femoral
diaphysis.
Marrow adipose tissue quantification (Osmium-mCT)
Quantification and visualization of marrow adipose tissue was
performed as described in Scheller et al. (2014). Briefly, long bones
were dissected free of soft tissues and fixed in 10% neutral buffered
formalin (cat# SF100-4, Fisher Scientific, Pittsburgh, PA) overnight
at 4˚Cwith gentle agitation. The following day, bones were washed
in cool running tap water. The bones were then decalcified in 4%
EDTA for 14 days at 4˚C, with EDTA changes every 3–4 days. The
boneswere then stained for lipid using a 1:1 mixture of 2% aqueous
osmium tetroxide (cat# 23310-10, Polysciences, Inc., Warrington,
PA) and 5% potassium dichromate for 48 h. The bones were then
washed in cool running tap water for 2 h. Whole bones were
imaged using micro-computed tomography (mCT) performed in
water with energy of 55 kVp, an integration time of 500msec, and a
maximum isometric voxel size of 10mm using a mCT-35 (Scanco
Medical, Bruttisellen, Switzerland).
Histomorphometry
Mice received intraperitoneal injections of 20mg/kg calcein
and 50mg/kg demeclocycline 10 and 3 days prior to sacrifice,
respectively, for the determination of bone formation rates.
At the time of sacrifice, limbs were placed in 70% ethanol and
maintained in the dark at room temperature. Quantitative static
and dynamic histomorphometry measurements were taken at the
secondary spongiosa of the proximal tibial metaphysis with the
OsteoMeasure morphometry system (Osteometrics, Atlanta,
GA).
Statistical analysis
All data are expressed as the mean the standard error of the
mean (SEM) unless otherwise noted. Statistically significant
differences for the long-term study were determined using an
unpaired Student’s t-test. A paired Student’s t-test was used
for the short-term pilot study. Differences were considered
statistically significant when P< 0.05.
Results
In the long-term study, HFD-fed mice had significantly higher
body weight than control-fed animals after 2 weeks of feeding
(HFD), and this parameter remained higher throughout the
study (Fig. 1A). Longitudinal measurements of whole-body
composition by dual-energy X-ray absorptiometry (DXA)
showed a significant increase in body fat percentage following
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12 weeks of HFD feeding as compared to controls (Fig. 1B). In
addition, MAT volume, quantified by osmium staining andmCT,
wasmore than fivefold higher inmice fed theHFD compared to
the control diet (Fig. 1C). However, areal bone mineral density
(aBMD) was not significantly different between control and
HFD-fed groups (Fig. 1D). Bone length was also unchanged as
compared to controls after 12 weeks of HFD in B6 mice (data
not shown). Micro-computed tomography (mCT) analysis at
the end of the 12-week diet study showed that B6 mice on a
HFD had no changes in femoral trabecular bone volume
fraction (BV/TV), yet displayed a slight but significant decrease
in trabecular number (Tb.N) and small increases in spacing (Tb.
Sp) and connectivity (Conn.D; Table 1). Analysis of cortical
bone at the mid-diaphysis indicated no significant differences
between control- and HFD-fed B6 mice. Histomorphometric
measurements revealed no changes in static parameters
including trabecular number, thickness, and spacing, nor in
dynamic parameters such as bone formation rate (BFR) and
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Fig. 1. Twelve-week high fat diet leads to increased weight, total body fat, and MAT, but areal BMD is unchanged. A: Male B6 mice on a HFD
had significantly higher body weight than controls after 12 weeks of feeding (P< 0.03). B: Total percent body fat by DXA showed increased fat
in HFD-fed mice (P< 0.001). C: Marrow adipose tissue volume was significantly increased in HFD-fed mice (P< 0.04). D: aBMD was unchanged
with HFD as compared to controls.
JOURNAL OF CELLULAR PHYSIOLOGY
2034 D O U C E T T E E T A L .
mineral apposition rate (MAR) in response to a HFD (Table 2).
Similarly, osteoblast and osteoclast number did not differ
between HFD-fed mice and controls.
Serum analyses showed increased insulin and leptin levels in
HFD-fed mice compared to controls (Fig. 2A,B), whereas
osteoprotegerin (OPG) levels were significantly reduced in
HFD-fed mice (Fig. 2C).We observed no significant differences
in levels of IL-6, DKK1, sclerostin (SOST), osteocalcin, or
FGF23 (data not shown). Additionally, there was a decrease in
serum levels of TNFa in B6 HFD-fed mice as compared to
controls (Fig. 2D).
We also initiated a short-term longitudinal study of male and
female B6 mice to assess the time course for generation of
MAT and its effects on bone mass. After 2 weeks of a HFD,
there were significant sex differences as the total body weight
of male B6 mice increased by 10.1% following 2 weeks of HFD
whereas the change in total body weight of female mice was
less than 1% (total body weight, male baseline: 27.53 0.99 g,
male post-2wk HFD: 30.30 0.93 g, P¼ 0.055 by paired t-test;
female baseline: 20.03 0.22 g, female post-2wk HFD:
20.20 0.45 g, P¼ 0.45 by paired t-test). NMR measurements
across the same interval showed that the increase in body
weight was primarily due to increased fat mass (data not
shown), and total areal BMD by DXAwas unchanged after two
weeks of HFD feeding in both males and females. By contrast,
both males and females exhibited very high MAT volumes
following 2 weeks of HFD feeding that were markedly different
from MAT measurements in an independent cohort of B6
males fed a control diet (age-matched B6 VIO2: 1.8 1.5% vs.
2wk HFD male VOI2: 58.7 8.4% and 2wk HFD female VOI2:
58.9 10.6%; Fig. 3). There was no difference in MAT volume
by sex at the 2-week time point; P¼ 0.98.
Discussion
In this study, we performed high-fat diet feeding in B6 mice to
test the hypothesis that increased MAT would negatively affect
the skeleton. We varied diet, sex, content of the diet, and
timing of HFD feeding, but maintained the same inbred strain in
order to minimize confounders. We found that bone
microarchitecture and cortical bone mass measured by mCT
showed little change after 12 weeks of a 60% HFD in young B6
male mice. Moreover, dynamic histomorphometry revealed no
statistically significant changes in bone formation, osteoblast or
osteoclast number, osteoclast surface/bone surface, or mineral
apposition rate. YetMAT volume increased dramatically during
this dietary intervention compared to control B6 mice fed a
regular diet. To clarify this response, we also undertook a pilot
study comparing aBMD and MAT measurements before and
after a 2-week 58%HFD (i.e., Surwit diet) in male and female B6
mice. Total and femoral aBMD were unchanged compared to
baseline, while MAT was high in comparison to an independent
cohort of 15-week-old male B6 mice. The skeletal changes we
found are in contrast to earlier studies demonstrating that
significant bone loss occurs in B6 mice fed a HFD (Cao et al.,
2010; Patsch et al., 2011). However, in contrast to our work
(i.e., 3-week-old mice, n¼ 10 per diet), in the Patsch study, high
fat feeding was started at an older age (i.e., 7 weeks of age) and
with smaller numbers of mice (n¼ 6).
HFD feeding increases adipocyte size and may also enhance
adipogenic proliferation which is associated with activation of
several adipogenic transcription factors including PPARg, C/
EBPa, and C/EBPb (Skurk et al., 2007; Harms and Seale, 2013).
These in turn lead to downstream regulation ofmany adipocyte
proteins such as CD36, FABP4, FASN, SREBP, and an array of
fatty acid transporters (Kajimura et al., 2008). As the adipocyte
enlarges, it can also secrete adipokines and cytokines such as
TNFa, IL-6, Pref-1, resistin, leptin, and adiponectin that could
influence surrounding bone remodeling units by increasing
resorption and suppressing formation (Skurk et al., 2007).
However, we found no evidence by histomorphometry of
changes in the remodeling sequence in B6 male mice following
12 weeks of high-fat feeding despite a marked increase in
MAT. Moreover, circulating IL-6 did not change during a
HFD and TNFa was lower in the HFD group as compared to
controls.
These findings are in contrast to inbred strains of mice,
including B6, fed rosiglitazone, which directly activates PPARg,
and MAT increases significantly in parallel with bone loss
(Ackert-Bicknell and Rosen, 2006; Lazarenko et al., 2007;
Ackert-Bicknell et al., 2009). Rosiglitazone has been shown to
have a dual effect on skeletal remodeling; that is, suppressing
bone formation through enhancement of PPARg activity and
inducing osteoclastogenesis by stimulation of Pgc1b expression
(Wei et al., 2010). It seems likely that ligand activation of PPARg
differs between rosiglitazone and HFD because the latter
does not stimulate Pgc1a or b, nor is there evidence from
histomorphometry that eroded surface, osteoclast number,
or bone resorption is increased. This is reinforced by studying
HFD-induced skeletal changes between B6 and the congenic
6Tmouse. The latter strain is associatedwith a gain-of-function
polymorphism in Ppargwhich leads to activation of this nuclear
receptor in a manner that is analogous to rosiglitazone-induced
activation. Thus it is conceivable that with a HFD in B6 mice,
specific fatty acid ligands may not activate Pparg to the extent
that this occurs with rosiglitazone or in the congenic 6T
background.
We found that circulating leptin levels increased after
12 weeks of HFD feeding in parallel with substantial weight gain
TABLE 1. Micro-computed tomography of the trabecular and cortical regions
of femora from control and high fat diet-fed mice.
C57BL/6J
Control HFD
Femur length (mm) 15.50 0.06 15.61 0.13
Trabecular
BV/TV (%) 15.6 0.55 13.7 1.9
Tb.N (1/mm) 4.88 0.07 4.39 0.19
Tb.Th (mm) 0.051 0.001 0.052 0.003
Tb.Sp (mm) 0.194 0.003 0.223 0.012
Conn.D (1/mm3) 114.33 7.90 98.61 14.14
Cortical
Tt.Ar (mm2) 2.09 0.04 2.23 0.07
Ma.Ar (mm2) 1.07 0.03 1.14 0.04
Ct.Ar (mm2) 1.03 0.01 1.09 0.04
Ct.Ar/Tt.Ar (%) 0.491 0.007 0.489 0.009
Ct.Th (mm) 0.227 0.003 0.227 0.005
Cort. porosity (%) 7.49 0.13 7.89 0.27
P< 0.05.
TABLE 2. Static and dynamic histomorphometry of tibiae from control and high
fat diet-fed mice
C57BL/6J
Control HFD
BV/TV (%) 19.33 1.91 17.80 1.09
OS/BS (%) 17.52 2.99 24.18 4.38
Ob.S/BS (%) 4.58 1.22 8.29 1.73
Oc.S/BS (%) 5.28 0.85 5.69 0.95
Tb.Th. (mm) 41.68 2.88 43.94 1.87
O.Th. (mm) 3.11 0.12 2.87 0.14
N.Ob/B.Pm (/mm) 4.10 1.08 7.47 1.54
N.Oc/B.Pm (/mm) 1.43 0.24 1.62 0.27
Tb.Sp. (mm) 178 12 206 12
Tb.N. (/mm) 4.61 0.21 4.06 0.21
MS/BS (%) 36.28 2.95 28.84 2.70
MAR (mm/day) 1.36 0.06 1.47 0.07
BFR/BS (mm3/mm2/day) 179.65 15.40 154.53 16.56
BFR/BV (%/year) 1,015 113 787 67
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Fig. 2. High fat diet-fed mice have increased circulating insulin, leptin, and osteocalcin levels. A: Serum insulin was increased in HFD-fed mice
after 12 weeks (P< 0.001), as was (B) leptin (P< 0.04), while levels of (C) osteoprotegerin and (D) TNFa were significantly reduced as
compared to control mice (P< 0.04).
Fig. 3. Mice fed a Surwit diet for 2 weeks have high volumes of marrow adipose tissue in both males and females.
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and greater fat mass, but these changes were not correlated
with changes in bone mass by mCT or bone remodeling
measured by histomorphometry. On the other hand, serum
levels of OPG were reduced and markers of inflammation such
as TNFa and IL-6 were not increased systemically by a HFD.
Notwithstanding, we cannot exclude the possibility that HFD-
inducedMAT releases factors that counterbalance any negative
effects from a HFD resulting in little change in the remodeling
sequence and therefore no changes in bone mass.
The rapid increase in MAT volume observed in our pilot
study is of particular interest due to our recent efforts to
characterize marrow adipogenesis and identify the MAT
progenitor. It has been hypothesized that marrow adipocytes
may be unique in their mesenchymal lineage and arise from a
distinct progenitor that differs from osteoblasts, white
adipocytes, and brown adipocytes (Horowitz et al., 2014). For
example, calorie restriction in mice and anorexia nervosa in
humans were associated with a marked increase in MAT as well
as a progressive decline in bone mass despite the relative
paucity of adipose stores in peripheral tissues (Devlin et al.,
2010; Bredella et al., 2009). Similarly in aging mammals, MAT is
markedly increased while bone volume fraction is reduced and
peripheral adipose depots are low (Duque, 2008). On the
other hand, during the early phases of lactation we reported
that MAT almost completely disappears, despite the very
pronounced loss of bone mass and the massive lipolysis in
peripheral adipocytes (Bornstein et al., 2014). We report here
that HFD feeding results in both increased peripheral and
marrow adipose tissue. Importantly, in the inbred strain C3H/
HeJ, MAT volume is much greater than in B6, yet both cortical
and trabecular bone mass are also high (Ackert-Bicknell and
Rosen, 2006). These data suggest that the inducer of MAT
(e.g., HFD, aging, calorie restriction, genetic background) may
signal not only the adipocyte progenitor but other cells in the
bone marrow resulting in changes in bone remodeling. Thus,
the purported reciprocal relationship between MAT and
trabecular bone mass is not a constant, nor is there a definitive
relationship between changes in peripheral white and
marrow adipose tissues. Therefore, the relationship among
MAT, white adipose tissue, and trabecular bone mass is
influenced by numerous factors that could mediate a shift in
MSC lineage.
In the longitudinal study, we sought to limit the confounding
variables that could affect the marrow and skeletal response to
a HFD. These included duration of high fat feeding, sex, inbred
strain, and diet content. Interestingly, mice fed a Surwit HFD
(58 kcal %) for just 2 weeks had extremely high MAT volumes,
but no change in areal BMD as compared to baseline.
Importantly, female mice showed the same high MAT volume
as the male mice even though only the latter gained weight.
Diet composition did not appear to influence the MAT volume
or bone response; the Surwit diet contains coconut oil as the
source of fat as opposed to the 60% HFD, which contains lard,
yet both diets appeared to have similar effects. Thus, it is clear
that MAT is exquisitely sensitive to nutritional influences and is
independent of body weight changes. This would raise the
possibility that MAT possesses unique fatty acid transporters
that can recycle these compounds more rapidly and efficiently
than other depots, either paradoxically in response to low
substrate availability or during dietary excesses. Whether this
reflects the unique location of this depot (i.e. the marrow) or
extrinsic factors needs to be elucidated by further studies
including lineage tracing experiments.
In conclusion, we found that HFD feeding increases MAT
volume but does not adversely affect skeletal remodeling in
young and adolescent B6 mice. Understanding the origin of the
marrow adipocyte within this niche and its relationship to
osteogenesis will provide greater insights into the role of
obesity, if any, in modulating skeletal mass.
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